You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 095342


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 095342

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Dec 28, 2032 Global Blood Theraps OXBRYTA voxelotor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent AR095342: Scope, Claims, and Patent Landscape in Argentina

Last updated: August 3, 2025

Introduction

Patent AR095342, filed in Argentina, represents a strategic intellectual property asset in the pharmaceutical sector. As local and international pharmaceutical companies navigate patent landscapes to protect innovative formulations and methods, understanding AR095342's scope and claims becomes essential. This analysis provides a detailed examination of the patent's claims, scope, and its position within Argentina's patent landscape, offering insights for stakeholders involved in licensing, litigation, or R&D.


Patent Overview and Filing Context

AR095342 was granted as a domestic patent in Argentina, reflecting recognition of novel, inventive, and industrially applicable aspects of the claimed invention. While the specific filing and priority dates are not disclosed herein, typical functions of such patents involve protection of a new chemical entity, formulation, or therapeutic method. Argentina’s patent law aligns broadly with the TRIPS Agreement, emphasizing patentability for pharmaceutical innovations while balancing public health considerations.


Scope and Claims Analysis

Claims Breakdown

The claims define the legal scope of patent protection. A typical pharmaceutical patent like AR095342 would include independent claims covering:

  • A novel chemical compound or pharmaceutical composition, possibly with unique substitutions or structural features.
  • A manufacturing process that yields the compound or formulation.
  • A therapeutic use or method of treatment involving the compound.

Given the pattern of pharmaceutical patents, AR095342 likely contains:

  • Independent claims centered on the chemical entity or composition.
  • Dependent claims that specify preferred embodiments, concentrations, or combinations.

Without direct access to the patent document, the following generalizations reflect standard pharmaceutical patent strategies.

Scope of Claims

1. The Chemical Compound Claim:

Most patent claims focus on an innovative molecule with specific chemical modifications imparting improved efficacy, stability, or reduced side effects. The scope here captures all analogs with the characterized structural features, providing broad protection against similar derivatives.

2. Formulation and Composition:

Claims may encompass pharmaceutical compositions comprising the compound, including excipients, carriers, or delivery systems. This scope aims to prevent generic firms from producing similar formulations without infringing on the patent.

3. Therapeutic Use:

Use claims often cover methods of treating specific diseases, such as cancer, neurological disorders, or infectious diseases, with the patented compound. These claims broaden protection by extending to medical indications.

4. Manufacturing Process:

Claims may also include methods of synthesizing the compound or formulation, safeguarding proprietary synthesis routes.

Claim Quality and Strategy

The robustness of a patent depends on:

  • Claim clarity and breadth: Well-drafted claims maximize scope without risking invalidity.
  • Disclosure sufficiency: Providing enough detail to enable practitioners to produce the invention.
  • Dependent claims: Strengthen protection by covering variants and improvements.

In the Argentine context, claims conforming to local patent standards must clearly delineate inventive steps and prevent overly broad assertions, particularly in chemical patents.


Patent Landscape in Argentina Related to AR095342

National Patent Environment

Argentina exhibits a dynamic but emerging pharmaceutical patent landscape, balancing innovation incentives and public health interests. The country complies with international standards, yet patent rights are subject to limitations, especially concerning patents on medicinal products, as per the Argentine Patents and Licenses Law (Ley de Patentes N° 24.371).

Patent Prior Art and Competitor Landscape

Patent applications in Argentina often cite prior art from global patent offices, including the USPTO, EPO, and WIPO. Local firms and multinational pharma companies file patents with incremental improvements or new therapeutic claims. In the context of AR095342, key considerations involve:

  • Existing patented compounds or formulations in Argentina.
  • Design-around strategies by competitors to avoid infringement.
  • Patent term and patent expiry dates, dictating market exclusivity.

Competitive Positioning

Depending on the scope, AR095342 may be:

  • The first patent covering a particular active pharmaceutical ingredient (API) or therapeutic use.
  • Part of a broader patent family protecting related formulations or synthesis methods.
  • Obstructed or challenged by third-party applications based on prior art or lack of inventive step.

Patent examination in Argentina closely scrutinizes novelty and inventive step, especially for pharmaceuticals, which often involves substantive search and opposition procedures. Companies must maintain vigilant monitoring to defend or challenge patent rights effectively.

Legal and Regulatory Considerations

Argentina's legal framework allows for compulsory licensing under certain conditions, especially during public health emergencies. Thus, patent holders need to assess the risk of patent challenges or licensing negotiations, particularly when commercializing patented drugs.


Implications of Patent Scope for Stakeholders

  • Innovators: The scope of AR095342 influences the scope of market exclusivity. Broad claims can prevent competitors from developing similar products but risk invalidation if too overly broad.

  • Generic manufacturers: Must analyze claim language meticulously to develop non-infringing alternatives, potentially by designing around narrowly claimed aspects or focusing on formulations not protected by the patent.

  • Legal practitioners: Need to scrutinize claim language during licensing or litigations. Effective patent drafting and examination are key to maintaining enforceability.

  • Regulatory authorities: Patent status impacts approval timelines and market authorization, especially considering Argentina's specific patent provisions and exceptions.


Conclusion

AR095342 exemplifies a strategic pharmaceutical patent in Argentina with a likely focus on a novel chemical entity, formulation, or therapeutic application. Its scope, defined by carefully drafted claims, plays a crucial role in positioning the patent holder within the local market and against potential infringers. Given Argentina’s evolving patent landscape, continuous monitoring and strategic patent management remain imperative for maximizing patent value and safeguarding innovation.


Key Takeaways

  • The patent’s claims likely cover chemical composition, formulations, and therapeutic uses, providing multiple layers of protection.
  • Well-drafted claims balance broad exclusive rights with robustness against invalidation.
  • The Argentine patent landscape emphasizes novelty and inventive step, with potential for challenges or opposition.
  • Stakeholders should evaluate claim scope diligently to devise effective infringement or licensing strategies.
  • Understanding patent landscapes allows for better R&D positioning, licensing negotiations, and risk management.

FAQs

1. What is the typical scope of pharmaceutical patent claims in Argentina?
They generally encompass the chemical molecule, formulations, therapeutic uses, and manufacturing processes. The claims must be precise, novel, and inventive to withstand examination.

2. How does Argentina’s patent law influence pharmaceutical patent protection?
Law emphasizes patentability on novelty and inventive step; however, provisions like compulsory licensing and patent term adjustments reflect public health priorities, affecting patent exploitation.

3. Can a patent like AR095342 be challenged post-grant?
Yes. Third parties may file oppositions based on prior art or lack of inventive step within applicable timeframes. Such challenges aim to narrow or revoke broad or invalid claims.

4. How do patent landscapes impact generic drug market entry in Argentina?
Broad patents delay generic entry; understanding claim scope informs manufacturers on designing around or challenging patents, fostering timely access to medicines.

5. How important is claim drafting in patent protection?
Critically important. Precise, well-structured claims maximize scope and enforceability, ensuring comprehensive protection against infringing products or processes.


References:
[1] Argentine Patents and Licenses Law (Ley de Patentes N° 24.371)
[2] World Intellectual Property Organization (WIPO) Patent Scope Database
[3] local patent analysis reports and legal summaries

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.